| Achaogen Closes $56 Million Venture Capital Funding |
|
|
| Friday, April 09, 2010 5:28:00 AM PDT | VentureDeal Staff |
South San Francisco, California -- Biotechnology company Achaogen has raised $56 million in its third round of institutional venture capital investment.
Achaogen is developing a pipeline of life-saving antibiotics, including a lead candidate for multi-drug-resistant bacterial infections.
Frazier Healthcare Ventures led the round, which included numerous top-tier venture capital firms. |
|
|
 Email Page |  Print Page |
|
|
|
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
|
 |
|
|
|
 |